Inoperable brain metastases from non-small cell lung cancer: what part does whole brain radiotherapy play in standard treatment?

Barton, Rachael
January 2008
Thorax;Jan2008, Vol. 63 Issue 1, p1
Academic Journal
The author discusses the ongoing randomized controlled trial called Quality of Life After Radiotherapy and Steroids (QUARTZ) in Great Britain and Australia. The trial, which is recruiting patients, aims to evaluate whether optimal supportive care alone is as effective as combined whole brain radiotherapy (WBRT) and optimal supportive care in the treatment of patients with inoperable brain metastases from non-small cell lung cancer (NSCLC).


Related Articles

  • Surgery in limited-disease small-cell lung cancer. Koul, Parvaiz A. // Lung India;Jan-Mar2012, Vol. 29 Issue 1, p2 

    The author reflects on the abandonment of surgery as a treatment of choice for patients with limited-disease small-cell lung cancer (LD-SCLC) due to the result of a randomized trial which revealed a survival difference between surgery and radiotherapy. An overview of some studies which show that...

  • Traitement des cancers bronchiques à petites cellules métastatiques en 2012. Baize, N. // Oncologie;May2012, Vol. 14 Issue 5, p320 

    Systemic chemotherapy plays a major role in the management of patients with Stage IV small-cell lung cancer(SCLC). Despite strong initial chemosensitivity, majority of patients relapse within a few months and few patients survive more than a year. Spontaneous prognosis is wrong for at least six...

  • Cetuximab plus chemoradiation safe, active in advanced NSCLC.  // Hem/Onc Today;12/10/2008, Vol. 9 Issue 22, p16 

    The article reports on the findings of a phase-2 trial regarding the effectiveness of and safety in using a combined cetuximab and chemoradiation in the treatment of patients with non-small cell lung cancer (NSCLC). A total of 93 patients participated in the study. Initially they received...

  • Stereotactic Body Radiation Therapy: Approaches in Early-Stage NSCLC. Nichols, Emma Hitt // MD Conference Express;Jun2014, Vol. 14 Issue 3, p17 

    Stereotactic body radiation therapy (SBRT) is effective in patients with early-stage non—small cell lung cancer (NSCLC) who are either medically inoperable or high-risk operable. This article discusses treatment approaches and considerations for the use of SBRT in this population.

  • Adjuvant therapy for non-small cell lung cancer. França, Letícia Barbosa; Oliveira, Márcia Aparecida; Small, Isabele Ávila; Zukin, Mauro; de Lima Araújo, Luiz Henrique // Jornal Brasileiro de Pneumologia;may2011, Vol. 37 Issue 3, p354 

    Objective: Adjuvant chemotherapy is recommended for most patients submitted to resection due to non-small cell lung cancer (NSCLC) staged as II or IIIA. However, although various chemotherapy regimens that include cisplatin have been used in phase III trials, the best choice remains unclear. The...

  • Neurological outcome after emergency radiotherapy in MSCC of patients with non-small cell lung cancer--a prospective trial. Rief, Harald; Heinhold, Rita C.; Petersen, Lina C.; Rieken, Stefan; Bruckner, Thomas; Moghaddam-Alvandi, Arash; Debus, Jürgen; Sterzing, Florian // Radiation Oncology;2013, Vol. 8 Issue 1, p1 

    Background: The aim of this trial was to investigate neurological outcome after emergency RT in MSCC of NSCLC patients with acute neurological deficit.Methods: This pilot trial was prospective, non-randomized, and monocentre, ten patients were treated from July 2012...

  • Prophylactic cranial irradiation for patients with small-cell lung cancer. Bunn Jr., Paul A.; Kelly, Karen // JNCI: Journal of the National Cancer Institute;2/1/95, Vol. 87 Issue 3, p161 

    Editorial. Comments on prophylactic cranial irradiation for patients with small cell lung cancer. Histological differentiation between small cell lung cancer and non-small cell lung cancer; Reduction of central nervous system metastases rate with prophylactic irradiation; Stratification of...

  • Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Arriagada, Rodrigo; Le Chevalier, Thierry // JNCI: Journal of the National Cancer Institute;2/1/95, Vol. 87 Issue 3, p183 

    Evaluates the effects of prophylactic cranial irradiation on brain metastasis, overall survival and late-occurring toxic effects in patients with small-cell lung cancer in complete remission. Decrease in risk of brain metastasis; Possible beneficial effect on overall survival; Trial design;...

  • Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer: excellent tolerance using subcutaneous amifostine for cytoprotection. Koukourakis, M.I.; Romanidis, K.; Froudarakis, M.; Kyrgias, G.; Koukourakis, G.V.; Retalis, G.; Bahlitzanakis, N. // British Journal of Cancer;8/12/2002, Vol. 87 Issue 4, p385 

    The substantial augmentation of the radiation sequelae during chemo-radiotherapy with novel drugs masks the real potential of such regimens. In this study we examined whether subcutaneous administration of amifostine can reduce the toxicity of a highly aggressive chemo-radiotherapy scheme with...


Read the Article


Sign out of this library

Other Topics